Article

Sodium-Glucose Cotransporter-2 Inhibitors and Cutaneous Adverse Reactions: A Systematic Review of Clinical Phenotypes, Time-to- Onset Profiles, and Management Strategies (2020–2026)

2026-07-15

Abstract excerpt

<title>Abstract</title> <p>Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are widely prescribed for type 2 diabetes mellitus, cardiovascular protection, and renal outcomes. However, accumulating real-world and clinical trial data have identified a diverse spectrum of cutaneous adverse reactions (CARs) associated with their use. The clinical phenotypes range from mild pruritus and maculopapular eruptions to se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 965fb43f-aaa7-50fb-ab44-6b98ce568b52
DOI: 10.21203/rs.3.rs-10330665/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Sodium-Glucose Cotransporter-2 Inhibitors and Cutaneous Adverse Reactions: A Systematic Review of Clinical Phenotypes, Time-to- Onset Profiles, and Management Strategies (2020–2026)DOI 10.21203/rs.3.rs-10330665/v1Read

Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature reviewSemantic proximity Read

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical ImplementationSemantic proximity Read

Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA DatabaseSemantic proximity Read

Clinical Phenotypes and the Clinical Course of Bullous Pemphigoid Receiving Dipeptidyl Pepitidase-4 Inhibitor Treatment: An Analysis of Cases in a Single Japanese Center.Semantic proximity Read

Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity Read

Laboratory Parameters as Determinants for The Course of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Semantic proximity Read

Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole-Induced Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis.Semantic proximity Read

Pharmacogenetic markers of severe cutaneous adverse drug reactions.Semantic proximity Read

Cutaneous adverse events associated with Rybrevant based on FDA Adverse Event Reporting System (FAERS) database from 2021 to 2024Semantic proximity Read

Clinical Phenotypes of Severe Cutaneous Drug Hypersensitivity Reactions.Semantic proximity Read

Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity Read

Severe Cutaneous Adverse Drug Reactions: From Causes to MechanismsSemantic proximity Read